Large gap with delayed quotes
Analysis date: 19.05.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 14.11.2025.
Interest
Strong
Strong
Three stars since 19.05.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 10.04.2026 at a price of 495.47.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 20.03.2026.
4wk Rel Perf
-20.27%
-20.27%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 20.27% behind the SP500.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.06.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.90%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.22%.
Mkt Cap in $bn
93.79
93.79
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
0.94
0.94
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
12.19
12.19
The estimated PE is for the year 2027.
LT Growth
10.71%
10.71%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
22
22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
0.79%
0.79%
The twelve month estimated dividend yield represents 9.60% of earnings forecasts.
Beta
22
22
For 1% of index variation, the stock varies on average by 0.22%.
Correlation
0.11
0.11
Stock movements are totally independent of index variations.
Value at Risk
48.60
48.60
The value at risk is estimated at USD 48.60. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2011
27.07.2011